NEWS
Dr. Chimezie Okwuonu Discloses Major Global Milestone as UVA Health System and FMC Umuahia Advance to Prestigious ISN–TTS Level B Kidney Transplant Status
Professor Dr. Chimezie Okwuonu has disclosed a major breakthrough in global healthcare collaboration following the official advancement of the partnership between the University of Virginia Health System, USA, and Federal Medical Centre (FMC), Umuahia, from Entry-Point Level C to Level B designation in the prestigious ISN–TTS Sister Transplant Centers Program.
The disclosure marks another historic achievement for FMC Umuahia and Nigeria’s growing kidney transplant sector, as the international partnership continues to record measurable progress in transplant care, research, manpower development, and patient outcomes.
The ISN–TTS Sister Transplant Centers Program, a collaborative initiative of the International Society of Nephrology and The Transplantation Society, was established to support the development of kidney transplant centers in emerging economies through strategic mentorship and technical collaboration with advanced transplant institutions worldwide.
The new Level B designation is regarded as a prestigious recognition reserved for high-performing transplant partnerships that have demonstrated outstanding progress in expanding kidney transplant capacity and improving healthcare delivery in resource-limited regions.
According to Prof. Dr. Chimezie Okwuonu, the partnership between UVA and FMC Umuahia has already produced significant clinical and academic achievements within its first two years.
Among the key achievements highlighted is the remarkable reduction in post-transplant hospital stay duration at FMC Umuahia, which has improved from 14 days to 8 days, reflecting enhanced efficiency in patient care and transplant management.
The collaboration has also strengthened local medical expertise through the successful training of four transplant coordinators and the conduct of four transplant pathology sessions aimed at improving diagnostic and clinical competence at the emerging transplant center.
In the area of research and academic advancement, the partnership has produced eight joint scientific publications focusing on kidney transplantation and therapeutic apheresis, further positioning FMC Umuahia within the global nephrology and transplant medicine community.
Prof. Dr. Okwuonu noted that the achievement goes beyond recognition, emphasizing that the Level B status represents a major step toward sustainable healthcare development and broader access to quality kidney transplant services in Nigeria and across West Africa.
The partnership, co-led by Dr. Rasheed Balogun, Professor in the Department of Medicine, Division of Nephrology at UVA, continues to focus on structured mentorship, multidisciplinary training, and institutional capacity building designed to create a scalable model for kidney care in the region.
The collaboration is now expected to intensify efforts toward attaining the highly coveted Level A designation within the ISN–TTS Sister Transplant Partnership framework, a move that would further strengthen FMC Umuahia’s standing as an emerging center of excellence in kidney transplantation in Africa.
The development has also been applauded as a reflection of the growing impact of international medical collaborations in addressing global disparities in kidney disease treatment and improving survival outcomes for patients in developing nations.
With this latest milestone, FMC Umuahia continues to gain international recognition as a rapidly advancing transplant institution, while the University of Virginia Health System further reinforces its reputation in global medical capacity-building and healthcare partnership development.